Investigation of the association between vitiligo and fasting blood sugar

Background and Aim: Vitiligo is a dermatologic disorder which has autoimmune and genetic basis. Different studies in the world have shown relationship of vitiligo with autoimmune disorders. The purpose of this study was to investigate the association between vitiligo and fasting blood sugar (FBS). Materials and Methods: This cross sectional study was performed between 2016 and 2019 and included 102 patients with vitiligo. Diagnosis of vitiligo was made by our dermatologist and FBS levels of the participants were measured. Results: Mean age of the patients and duration of the disease were 39.7±15.8 years and 56.1±34.1 months respectively. 45 (%44) patients were male, the disorder was most frequent in the housewives. The most common site of involvement was genitalia which was affected in 52 (%31) cases, and the least common site was oral mucosa which was involved in 6 patients (%3.6). Only 4 (%2.7) patients had family history of vitiligo. Conclusions: The results showed that there were no significant association between vitiligo and variables of FBS, gender, occupation, site of involvement, family history of vitiligo, history of using medications and also any other disease.

[1]  Niti Khunger,et al.  Vitiligo and Other Disorders of Hypopigmentation , 2018 .

[2]  T. Mubki,et al.  Association of vitiligo with anemia, vitamin B12 deficiency, diabetes mellitus, and thyroid dysfunction in Saudi Arab patients: A case control study , 2017 .

[3]  S. Benvenga,et al.  The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients. , 2016, Autoimmunity reviews.

[4]  Y. H. Kumar,et al.  Increased prevalence of thyroid dysfunction and diabetes mellitus in Indian vitiligo patients: A case-control study , 2014, Indian dermatology online journal.

[5]  M. Fatani,et al.  The clinical patterns of vitiligo “hospital-based study” in Makkah region, Saudi Arabia , 2014 .

[6]  D. Cooper,et al.  The incidence and prevalence of thyroid autoimmunity , 2012, Endocrine.

[7]  D. Shankar,et al.  Clinical patterns of vitiligo and its associated co morbidities: A prospective controlled cross-sectional study in South India , 2012, Indian dermatology online journal.

[8]  M. Diallo,et al.  The Vitiligo in Senegal , 2012, ISRN dermatology.

[9]  Usha,et al.  Epidemiological profile of vitiligo in Northern India , 2011 .

[10]  D. Ertuğrul,et al.  Insulin resistance is increased in patients with vitiligo. , 2011, Acta dermato-venereologica.

[11]  R. Reghu,et al.  EPIDEMIOLOGICAL PROFILE AND TREATMENT PATTERN OF VITILIGO IN A TERTIARY CARE TEACHING HOSPITAL , 2011 .

[12]  M. Maleki,et al.  Evaluation of Subtypes of Peripheral Blood Lymphocytes in Patients with Vitiligo , 2009 .

[13]  L. Ersoy,et al.  Clinical characteristics in 113 Turkish vitiligo patients. , 2008, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.

[14]  V. Sehgal,et al.  Vitiligo: compendium of clinico-epidemiological features. , 2007, Indian journal of dermatology, venereology and leprology.

[15]  Y. H. Kumar,et al.  Vitiligo: a part of a systemic autoimmune process. , 2007, Indian journal of dermatology, venereology and leprology.

[16]  W. Westerhof,et al.  Evaluation of the effects of NB‐UVB in both segmental and non‐segmental vitiligo affecting different body sites , 2006, Photodermatology, photoimmunology & photomedicine.

[17]  R. Begum,et al.  Vitiligo: Clinical profiles in Vadodara, Gujarat , 2006 .

[18]  R. Schwartz,et al.  Vitiligo: a sign of systemic disease. , 2006, Indian journal of dermatology, venereology and leprology.

[19]  J. Naeyaert,et al.  Evidence for an autoimmune pathogenesis of vitiligo. , 2003, Pigment cell research.

[20]  M. Westhofen,et al.  Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. , 1994, Dermatology.

[21]  S A M JOHNSON,et al.  The cutaneous manifestations of diabetes mellitus. , 1948, The Nebraska state medical journal.